Drug Profile
Cyclocreatine phosphate
Alternative Names: cyclocreatine-phosphate-AmiraLatest Information Update: 20 Sep 2006
Price :
$50
*
At a glance
- Originator Amira
- Class
- Mechanism of Action Creatine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 12 Mar 1999 New profile
- 12 Mar 1999 Preclinical development for Cancer in USA (Unknown route)